Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
RNAi
Sort By
Newest First
Sign in
1 / 1
1 / 1
Series C Financing
Sirnaomics Closes $47 Million Series C Financing to Develop RNAi Therapeutics for Treatment of Cancer and Fibrotic Diseases
Sirnaomics, Inc.
PR-M04-19-NI-091
Apr 30, 2019
RNAi
Eli Lilly, Dicerna to Collaborate on RNAi Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-M11-18-NI-006
Nov 05, 2018
